Lanreotide Protein

CAT: 0247-OPPA01047-200UGSize: 200 µgDry Ice: NoHazardous: No
CAT#:0247-OPPA01047-200UGSize:200 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Gene Aliases
Lanreotide, Lanreotide
Target
Lanreotide is a peptide inhibitor of a number of endocrine, neuroendocrine, exocrine and paracrine functions. It shows good affinity for peripheral somatostatin receptors (anterior pituitary and pancreatic) . In contrast, its affinity for central receptors is much lower. This profile confers a good specificity of action at the level of growth hormone and digestive hormone secretion. Lanreotide shows a much longer duration of action than natural somatostatin. In addition, its marked selectivity for the secretion of growth hormone, compared to that of insulin, makes it a suitable candidate for the treatment of acromegaly. By inhibiting the synthesis of thyroid stimulating hormone (TSH), lanreotide also normalised thyroid function of patients with thyrotrophin secreting adenomas in 50% (8/16) of the per-protocol population treated for 6 months. There was no significant reduction in the size of the adenoma. Lanreotide is an octapeptide, an analogue of a naturally occurring hormone, somatostatin.
Type
Protein
Assay Protocol
Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol
Concentration
1 mg/ml
Format
Lyophilized// 5 mg manntitol and 0.04mg tween-80 Physical Appearance:// Sterile filtered white freeze-dried powderPhysical Appearance:// Sterile filtered white freeze-dried powder
Reconstitution
2
Notes
Formerly GWB-58558C
NCBI Gene Symbol
LANREOTIDE
Gene Name URL
Lanreotide

Related Products

CatalogName
OPSB02901-1MGProtein A Protein
OPSB02900-5MGProtein A Protein
OPPA01269-10MGProtein A Protein
OPSA10755-5MGPROTEIN G Protein
OPPA01758-1MGProtein A/G Protein
OPPA01314-1MGProtein G Protein
OPSB02902-1MLProtein A Protein : HRP
OPCA02991-100UGCore protein Recombinant Protein
OPCA02991-20UGCore protein Recombinant Protein
OPSA10734-1MLPROTEIN G:HRP Protein

Alternative Products

CatalogName
32-2047-1Lanreotide Protein
QP12536-1mgRecombinant other Lanreotide Protein, Untagged, E.coli-1mg
QP12536-200ugRecombinant other Lanreotide Protein, Untagged, E.coli-200ug
QP12536-10mgRecombinant other Lanreotide Protein, Untagged, E.coli-10mg
PT_41366-01Lanreotide (Lanreotide)
BITH3031-01Lanreotide
HY-P1959A-01Lanreotide (acetate)
sc-488702Lanreotide Acetate

Popular Products